These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7057798)

  • 1. Mutagenic evaluation of carcinogens and non-carcinogens in the L5178Y/TK assay utilizing postmitochondrial fractions (S9) from normal rat liver.
    Amacher DE; Turner GN
    Mutat Res; 1982 Feb; 97(1):49-65. PubMed ID: 7057798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promutagen activation by rodent-liver postmitochondrial fractions in the L5178Y/TK cell mutation assay.
    Amacher DE; Turner GN
    Mutat Res; 1980 Dec; 74(6):485-501. PubMed ID: 7464853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methapyrilene is a genotoxic carcinogen: studies on methapyrilene and pyrilamine in the L5178Y/TK +/- mouse lymphoma assay.
    Turner NT; Woolley JL; Hozier JC; Sawyer JR; Clive D
    Mutat Res; 1987 Nov; 189(3):285-97. PubMed ID: 3670332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. II. Test validation and interpretation.
    Amacher DE; Paillet SC; Turner GN; Ray VA; Salsburg DS
    Mutat Res; 1980 Aug; 72(3):447-74. PubMed ID: 7453708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity of rat-liver S9 to L5178Y mouse lymphoma cells.
    Myhr BC; Mayo JK
    Mutat Res; 1987 Sep; 189(1):27-37. PubMed ID: 3627149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay to coded chemicals. I: Results for nine compounds.
    McGregor DB; Martin R; Cattanach P; Edwards I; McBride D; Caspary WJ
    Environ Mutagen; 1987; 9(2):143-60. PubMed ID: 3102223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the activities of benzo[a]pyrene, benzidine and ethyl methanesulphonate in the L5178Y TK +/- mouse lymphoma mutagenicity assay using standardized and non-standardized protocols.
    Riach CG; Cattanach PJ; Howgate S; Shepherd W; McBride D; Edwards IW; McGregor DB; Combes RD
    Mutagenesis; 1990; 5 Suppl():35-44. PubMed ID: 2184319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of liver postmitochondrial fraction concentration from Aroclor 1254-treated rats on promutagen activation in L5178Y cells.
    Amacher DE; Turner GN
    Mutat Res; 1982 Apr; 97(2):131-7. PubMed ID: 7078576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay. II: 18 coded chemicals.
    McGregor DB; Brown A; Cattanach P; Edwards I; McBride D; Caspary WJ
    Environ Mol Mutagen; 1988; 11(1):91-118. PubMed ID: 3338442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procarbazine is a potent mutagen at the heterozygous thymidine kinase (tk +/-) locus of mouse lymphoma assay.
    Clive D; Turner N; Krehl R
    Mutagenesis; 1988 Mar; 3(2):83-7. PubMed ID: 3288842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of an S9-based metabolic activation system used in the mouse lymphoma L5178Y cell mutation assay.
    McGregor DB; Edwards I; Riach CG; Cattanach P; Martin R; Mitchell A; Caspary WJ
    Mutagenesis; 1988 Nov; 3(6):485-90. PubMed ID: 3070287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microwell mutation assays: evaluation of ethylmethanesulphonate, benzo[a]pyrene and benzidine using the tk locus in L5178Y mouse lymphoma cells.
    Clay P; Cross MF
    Mutagenesis; 1990; 5 Suppl():45-54. PubMed ID: 2184320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotoxicity of 6 oxime compounds in the salmonella/mammalian-microsome assay and mouse lymphoma TK +/- assay.
    Rogers-Back AM; Lawlor TE; Cameron TP; Dunkel VC
    Mutat Res; 1988 Feb; 204(2):149-62. PubMed ID: 3278206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical mutagenesis at the thymidine kinase locus in L5178Y mouse lymphoma cells: results for 31 coded compounds in the National Toxicology Program.
    Myhr BC; Caspary WJ
    Environ Mol Mutagen; 1991; 18(1):51-83. PubMed ID: 1864269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of human liver S9 in the Ames test: assay of three procarcinogens using human S9 derived from multiple donors.
    Hakura A; Suzuki S; Sawada S; Sugihara T; Hori Y; Uchida K; Kerns WD; Sagami F; Motooka S; Satoh T
    Regul Toxicol Pharmacol; 2003 Feb; 37(1):20-7. PubMed ID: 12662906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide: lack of mutagenic activity across phyla and genetic endpoints.
    Ashby J; Tinwell H; Callander RD; Kimber I; Clay P; Galloway SM; Hill RB; Greenwood SK; Gaulden ME; Ferguson MJ; Vogel E; Nivard M; Parry JM; Williamson J
    Mutat Res; 1997 Dec; 396(1-2):45-64. PubMed ID: 9434859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of mutations in mouse lymphoma L5178Y cells by ethylmethanesulphonate, benzidine and benzo[a]pyrene.
    Henderson L; Ransome S; Brabbs C; Tinner A; Davies S
    Mutagenesis; 1990; 5 Suppl():27-34. PubMed ID: 2184317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenic activity of 5 thiazole compounds in the Salmonella/microsome and mouse lymphoma TK+/- assays.
    Cameron TP; Hughes TJ; Kirby PE; Palmer KA; Fung VA; Dunkel VC
    Mutat Res; 1985; 155(1-2):17-25. PubMed ID: 3881663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of the L5178Y TK+/- mouse lymphoma forward mutation assay using 42 chemicals.
    Oberly TJ; Bewsey BJ; Probst GS
    Mutat Res; 1984 Feb; 125(2):291-306. PubMed ID: 6700611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system.
    Clive D; Johnson KO; Spector JF; Batson AG; Brown MM
    Mutat Res; 1979 Jan; 59(1):61-108. PubMed ID: 372791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.